Aimee K. Ryan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aimee K. Ryan has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Indra Rani Gupta
Department of Pediatrics, Division of Pediatric Nephrology, Montreal Children's Hospital, McGill University Health Centre, McGill University, Montreal, Quebec, Canada; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
7 shared publications - Michelle M. Collins
Department of Anatomy, Physiology, and Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Canada
5 shared publications Amanda I. Baumholtz
Department of Human Genetics, McGill University, Montreal, QC, Canada
3 shared publicationsAnnie Simard
The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
3 shared publications- Elizabeth-Ann Legere
Department of Human Genetics, McGill University, Montreal, Canada
3 shared publications - Amanda I. Baumholtz
Department of Human Genetics, McGill University, Canada; The Research Institute of the McGill University Health Centre, Montréal, Québec, Canada
2 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Springer Nature in Communications Biology
Epithelial tissue architecture acts as a barrier to carcinoma initiation
- 29 September 2026
- Published by Springer Nature in Communications Biology
Open AccessEpithelial tissue architecture acts as a barrier to carcinoma initiation
- Open Access
- 15 September 2026
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 139 (18)
Increased tissue tension caused by depletion of CLDN3 in the non-neural ectoderm causes neural tube defects in chick embryos
Neural tube morphogenesis provides a dynamic setting in which to study epithelial cell behaviours. Here, we examined CLDN3-dependent biomechanical properties of the non-neural ectoderm during neural tube closure in chick embryos. Previous analyses of static images of chick embryos suggested that spinal neural tube closure occurs through multiple contact points or ‘buttoning’. Using live imaging and transverse cuts through the neural folds we confirmed the multiple simultaneous ‘buttoning’ contacts along the anterior-posterior axis and showed that spinal neural fold fusion is not the result of progressive ‘zippering’ cell behaviours as is required in cranial and posterior neuropore regions. CLDN3 depletion decreased the rate of neural fold closure between points of contact and increased phosphorylated myosin light chain (pMLC) within the apical domain of non-neural ectoderm cells, suggesting increased actomyosin contraction. Laser ablation studies revealed that CLDN3-depleted embryos exhibited higher tension across the non-neural ectoderm during neural fold fusion. Decreasing tension with blebbistatin rescued the neural fold fusion defects in CLDN3-depleted embryos. Our data support the importance of CLDN3 to regulate tissue tension through effects on cytoskeletal dynamics in the non-neural ectoderm during neural fold fusion.
- 15 September 2026
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 139 (18)
Open AccessIncreased tissue tension caused by depletion of CLDN3 in the non-neural ectoderm causes neural tube defects in chick embryos
Neural tube morphogenesis provides a dynamic setting in which to study epithelial cell behaviours. Here, we examined CLDN3-dependent biomechanical properties of the non-neural ectoderm during neural tube closure in chick embryos. Previous analyses of static images of chick embryos suggested that spinal neural tube closure occurs through multiple contact points or ‘buttoning’. Using live imaging and transverse cuts through the neural folds we confirmed the multiple simultaneous ‘buttoning’ contacts along the anterior-posterior axis and showed that spinal neural fold fusion is not the result of progressive ‘zippering’ cell behaviours as is required in cranial and posterior neuropore regions. CLDN3 depletion decreased the rate of neural fold closure between points of contact and increased phosphorylated myosin light chain (pMLC) within the apical domain of non-neural ectoderm cells, suggesting increased actomyosin contraction. Laser ablation studies revealed that CLDN3-depleted embryos exhibited higher tension across the non-neural ectoderm during neural fold fusion. Decreasing tension with blebbistatin rescued the neural fold fusion defects in CLDN3-depleted embryos. Our data support the importance of CLDN3 to regulate tissue tension through effects on cytoskeletal dynamics in the non-neural ectoderm during neural fold fusion.
- Open Access
- 16 July 2026
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 19 (10)
Novel associations of Claudin gene variants with kidney stone disease
Background: The tight junction family of claudin proteins regulates paracellular ion transport in the nephron and across epithelial and endothelial barriers throughout the body. Rare recessive variants in CLDN16 and CLDN19 cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), while common variants in CLDN2, CLDN10, and CLDN14 have been associated with kidney stones. Despite evidence that most claudin proteins are expressed within the nephron, their genetic contribution to kidney stone susceptibility has not been systematically explored. Methods: We analyzed 415 237 UK Biobank participants (9009 kidney stone cases and 406 228 controls) using exome sequencing and imputed genotype data spanning all 24 human CLDN genes. Single-variant association testing, gene burden analysis, and phenome-wide association studies were employed to identify novel associations. Results: Forty-three novel coding variant associations were identified through exome sequencing, including two CLDN16 variants: p.Gly57Arg (rs747654138; odds ratio [OR] = 42.2, P = 9.5 × 10−8) and p.Arg146His (rs772241737; OR = 60.5, P = 8.1 × 10−4). We replicated a known association with a CLDN19 variant, p.Arg200Gln (rs116804195; OR = 1.23, P = 2.6 × 10−4), which was also associated with decreased serum phosphate and increased alkaline phosphatase. We also identified 13 novel susceptibility loci within the imputed genotype dataset, including single nucleotide polymorphisms near CLDN2, CLDN10, CLDN11, CLDN18, and CLDN22–CLDN24 (all P < 0.00025), and confirmed a known CLDN14 association. Conclusions: Beyond established FHHNC genes, multiple CLDN family members harbor variants potentially influencing kidney stone risk, possibly through altered paracellular transport and mineral homeostasis. These findings expand kidney stone genetic architecture and suggest that claudin proteins merit further investigation in its pathogenesis.
- 16 July 2026
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 19 (10)
Open AccessNovel associations of Claudin gene variants with kidney stone disease
Background: The tight junction family of claudin proteins regulates paracellular ion transport in the nephron and across epithelial and endothelial barriers throughout the body. Rare recessive variants in CLDN16 and CLDN19 cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), while common variants in CLDN2, CLDN10, and CLDN14 have been associated with kidney stones. Despite evidence that most claudin proteins are expressed within the nephron, their genetic contribution to kidney stone susceptibility has not been systematically explored. Methods: We analyzed 415 237 UK Biobank participants (9009 kidney stone cases and 406 228 controls) using exome sequencing and imputed genotype data spanning all 24 human CLDN genes. Single-variant association testing, gene burden analysis, and phenome-wide association studies were employed to identify novel associations. Results: Forty-three novel coding variant associations were identified through exome sequencing, including two CLDN16 variants: p.Gly57Arg (rs747654138; odds ratio [OR] = 42.2, P = 9.5 × 10−8) and p.Arg146His (rs772241737; OR = 60.5, P = 8.1 × 10−4). We replicated a known association with a CLDN19 variant, p.Arg200Gln (rs116804195; OR = 1.23, P = 2.6 × 10−4), which was also associated with decreased serum phosphate and increased alkaline phosphatase. We also identified 13 novel susceptibility loci within the imputed genotype dataset, including single nucleotide polymorphisms near CLDN2, CLDN10, CLDN11, CLDN18, and CLDN22–CLDN24 (all P < 0.00025), and confirmed a known CLDN14 association. Conclusions: Beyond established FHHNC genes, multiple CLDN family members harbor variants potentially influencing kidney stone risk, possibly through altered paracellular transport and mineral homeostasis. These findings expand kidney stone genetic architecture and suggest that claudin proteins merit further investigation in its pathogenesis.
- Open Access
- 5 March 2026
- Published by Wiley in Birth Defects Research
- Vol. 118 (3) , e70037
No Evidence of Impact of Genetic Sex on Hyperthermia‐Induced Neural Tube Defects in Chicken Embryos
Background: In mammals, cranial neural tube defects (NTDs) are more likely to occur in females. It has been proposed that the sex bias in NTDs was due to the presence of the inactive X chromosome in the somatic cells of female embryos and that the inactive X acted as a heterochromatic sink, competing for silencing factors with the rest of the genome. Such competition increased the likelihood of abnormal gene regulation. To test this hypothesis, we used an animal model that lacks dosage compensation, the chicken Gallus gallus . If the heterochromatic sink hypothesis was correct, no sex bias will be found in chicken embryos with cranial NTDs. Methods: We used in ovo heat treatment to induce NTDs in chicken embryos and PCR genotyping to determine embryos' genetic sex. Embryo phenotypes were examined using a dissecting microscope. Embryos were staged according to Hamburger and Hamilton criteria and scored for NTDs. Results: We observed a statistically significant increase in NTDs following heat treatment (38.1% in the treatment group vs. 5.9% in the control group), but no sex bias. Next, we asked if heat treatment led to a developmental delay and found a significant association between the numbers of somite pairs and heat treatment and a reduced number of somites in the chicken embryos with cranial NTDs. Conclusion: In ovo hyperthermia during the developmental window when the neural tube is formed dramatically increases the rate of NTDs and delays the development of chicken embryos. However, there is no sex bias with respect to NTD risk.
- 5 March 2026
- Published by Wiley in Birth Defects Research
- Vol. 118 (3) , e70037
Open AccessNo Evidence of Impact of Genetic Sex on Hyperthermia‐Induced Neural Tube Defects in Chicken Embryos
Background: In mammals, cranial neural tube defects (NTDs) are more likely to occur in females. It has been proposed that the sex bias in NTDs was due to the presence of the inactive X chromosome in the somatic cells of female embryos and that the inactive X acted as a heterochromatic sink, competing for silencing factors with the rest of the genome. Such competition increased the likelihood of abnormal gene regulation. To test this hypothesis, we used an animal model that lacks dosage compensation, the chicken Gallus gallus . If the heterochromatic sink hypothesis was correct, no sex bias will be found in chicken embryos with cranial NTDs. Methods: We used in ovo heat treatment to induce NTDs in chicken embryos and PCR genotyping to determine embryos' genetic sex. Embryo phenotypes were examined using a dissecting microscope. Embryos were staged according to Hamburger and Hamilton criteria and scored for NTDs. Results: We observed a statistically significant increase in NTDs following heat treatment (38.1% in the treatment group vs. 5.9% in the control group), but no sex bias. Next, we asked if heat treatment led to a developmental delay and found a significant association between the numbers of somite pairs and heat treatment and a reduced number of somites in the chicken embryos with cranial NTDs. Conclusion: In ovo hyperthermia during the developmental window when the neural tube is formed dramatically increases the rate of NTDs and delays the development of chicken embryos. However, there is no sex bias with respect to NTD risk.
- Open Access
Mouse nephron formation is impaired by moderate-dose arsenical exposure
Background: Arsenic is a naturally occurring toxicant and industrial byproduct with significant health risks. Globally, millions of people are exposed to arsenic concentrations that exceed the World Health Organization’s recommended limit of 10 μg/L. Chronic arsenic exposure is linked to an increased risk of chronic kidney disease (CKD); however, the effects of arsenic exposure on kidney development remain unclear. Eukaryotes methylate inorganic arsenic (iAsIII) using the enzyme arsenic 3 methyltransferase (As3mt), that converts it to methylated intermediates, mono and dimethyl arsonous acid (MMAIII and DMAIII), and mono and dimethyl arsonic acid (MMAV and DMAV). We hypothesized that arsenicals exposure during mouse kidney development impairs nephron formation. Methods: Cultured mouse embryonic kidney explants were treated with inorganic arsenite (iAsIII), MMAIII, MMAV, and DMAV. Female mice harboring a humanized version of AS3MT and wild-type mice with murine As3mt were exposed to iAsIII throughout gestation and weaning and their offspring were analyzed for kidney defects. Results: Inorganic arsenic, iAsIII (200 μg/L), inhibited ureteric bud branching morphogenesis and growth of mouse kidneys at embryonic day 11.5 (E11.5) and E12.5, but not at E13.5. MMAIII, but not MMAV or DMAV, impaired ureteric bud branching and kidney explant growth. Additionally, iAsIII exposure increased apoptosis in the metanephric mesenchyme of E11.5 explants and decreased Gdnf transcription, which may explain the impairment in ureteric bud branching. Humanized mouse pups exposed to 200 μg/L iAsIII in utero , showed a 20% reduction in kidney weight normalized to body weight and a 28% reduction in nephron number, compared to kidneys of wild-type mice. Conclusion: Exposure to arsenicals during embryonic development impairs ureteric bud branching morphogenesis and decreases nephron endowment, which may predispose to CKD in adulthood.
Open AccessMouse nephron formation is impaired by moderate-dose arsenical exposure
Background: Arsenic is a naturally occurring toxicant and industrial byproduct with significant health risks. Globally, millions of people are exposed to arsenic concentrations that exceed the World Health Organization’s recommended limit of 10 μg/L. Chronic arsenic exposure is linked to an increased risk of chronic kidney disease (CKD); however, the effects of arsenic exposure on kidney development remain unclear. Eukaryotes methylate inorganic arsenic (iAsIII) using the enzyme arsenic 3 methyltransferase (As3mt), that converts it to methylated intermediates, mono and dimethyl arsonous acid (MMAIII and DMAIII), and mono and dimethyl arsonic acid (MMAV and DMAV). We hypothesized that arsenicals exposure during mouse kidney development impairs nephron formation. Methods: Cultured mouse embryonic kidney explants were treated with inorganic arsenite (iAsIII), MMAIII, MMAV, and DMAV. Female mice harboring a humanized version of AS3MT and wild-type mice with murine As3mt were exposed to iAsIII throughout gestation and weaning and their offspring were analyzed for kidney defects. Results: Inorganic arsenic, iAsIII (200 μg/L), inhibited ureteric bud branching morphogenesis and growth of mouse kidneys at embryonic day 11.5 (E11.5) and E12.5, but not at E13.5. MMAIII, but not MMAV or DMAV, impaired ureteric bud branching and kidney explant growth. Additionally, iAsIII exposure increased apoptosis in the metanephric mesenchyme of E11.5 explants and decreased Gdnf transcription, which may explain the impairment in ureteric bud branching. Humanized mouse pups exposed to 200 μg/L iAsIII in utero , showed a 20% reduction in kidney weight normalized to body weight and a 28% reduction in nephron number, compared to kidneys of wild-type mice. Conclusion: Exposure to arsenicals during embryonic development impairs ureteric bud branching morphogenesis and decreases nephron endowment, which may predispose to CKD in adulthood.
- Open Access
- 12 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (10) , 5280
A Nuclear Magnetic Resonance (NMR)- and Mass Spectrometry (MS)-Based Saturation Kinetics Model of a Bryophyllum pinnatum Decoction as a Treatment for Kidney Stones
Bryophyllum pinnatum (BP) is a medicinal plant used to treat many conditions when taken as a leaf juice, leaves in capsules, as an ethanolic extract, and as herbal tea. These preparations have been chemically analyzed except for decoctions derived from boiled green leaves. In preparation for a clinical trial to validate BP tea as a treatment for kidney stones, we used NMR and MS analyses to characterize the saturation kinetics of the release of metabolites. During boiling of the leaves, (a) the pH decreased to 4.8 within 14 min and then stabilized; (b) regarding organic acids, citric and malic acid were released with maximum release time (tmax) = 35 min; (c) for glycoflavonoids, quercetin 3-O-α-L-arabinopyranosyl-(1 → 2)-α-L-rhamnopyranoside (Q-3O-ArRh), myricetin 3-O-α-L-arabinopyranosyl-(1 → 2)-α-L-rhamnopyranoside (M-3O-ArRh), kappinatoside, myricitrin, and quercitrin were released with tmax = 5–10 min; and (d) the total phenolic content (TPC) and the total antioxidant capacity (TAC) reached a tmax at 55 min and 61 min, respectively. In summary, 24 g of leaves boiled in 250 mL of water for 61 min ensures a maximal release of key water-soluble metabolites, including organic acids and flavonoids. These metabolites are beneficial for treating kidney stones because they target oxidative stress and inflammation and inhibit stone formation.
- 12 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (10) , 5280
Open AccessA Nuclear Magnetic Resonance (NMR)- and Mass Spectrometry (MS)-Based Saturation Kinetics Model of a Bryophyllum pinnatum Decoction as a Treatment for Kidney Stones
Bryophyllum pinnatum (BP) is a medicinal plant used to treat many conditions when taken as a leaf juice, leaves in capsules, as an ethanolic extract, and as herbal tea. These preparations have been chemically analyzed except for decoctions derived from boiled green leaves. In preparation for a clinical trial to validate BP tea as a treatment for kidney stones, we used NMR and MS analyses to characterize the saturation kinetics of the release of metabolites. During boiling of the leaves, (a) the pH decreased to 4.8 within 14 min and then stabilized; (b) regarding organic acids, citric and malic acid were released with maximum release time (tmax) = 35 min; (c) for glycoflavonoids, quercetin 3-O-α-L-arabinopyranosyl-(1 → 2)-α-L-rhamnopyranoside (Q-3O-ArRh), myricetin 3-O-α-L-arabinopyranosyl-(1 → 2)-α-L-rhamnopyranoside (M-3O-ArRh), kappinatoside, myricitrin, and quercitrin were released with tmax = 5–10 min; and (d) the total phenolic content (TPC) and the total antioxidant capacity (TAC) reached a tmax at 55 min and 61 min, respectively. In summary, 24 g of leaves boiled in 250 mL of water for 61 min ensures a maximal release of key water-soluble metabolites, including organic acids and flavonoids. These metabolites are beneficial for treating kidney stones because they target oxidative stress and inflammation and inhibit stone formation.
- Open Access
- 27 December 2023
- Published by Elsevier in Developmental Biology
- Vol. 507, 20-33
Claudin-3 in the non-neural ectoderm is essential for neural fold fusion in chicken embryos
- 27 December 2023
- Published by Elsevier in Developmental Biology
- Vol. 507, 20-33
Open AccessClaudin-3 in the non-neural ectoderm is essential for neural fold fusion in chicken embryos
- Open Access
- 25 September 2020
- Published by Wiley in Physiological Reports
- Vol. 8 (18)
Role of Claudins in Renal Branching Morphogenesis
We demonstrate that removal of multiple claudins from tight junctions within the ureteric bud lineage impairs branching morphogenesis in a mouse embryonic kidney explant model. Fewer ureteric bud tip...
- 25 September 2020
- Published by Wiley in Physiological Reports
- Vol. 8 (18)
Open AccessRole of Claudins in Renal Branching Morphogenesis
We demonstrate that removal of multiple claudins from tight junctions within the ureteric bud lineage impairs branching morphogenesis in a mouse embryonic kidney explant model. Fewer ureteric bud tip...
- Open Access
- 14 July 2020
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 14, 664
Functional Validation of CLDN Variants Identified in a Neural Tube Defect Cohort Demonstrates Their Contribution to Neural Tube Defects
Neural tube defects (NTDs) are severe malformations of the central nervous system that affect 1-2 individuals per 2000 births. Their etiology is complex and involves both genetic and environmental factors. Our recent discovery that simultaneous removal of Cldn3, -4 and -8 from tight junctions results in cranial and spinal NTDs in both chick and mouse embryos suggests that claudins play a conserved role in neural tube closure in vertebrates. To determine if claudins were associated with NTDs in humans, we used a Fluidigm next generation sequencing approach to identify genetic variants in CLDN loci in 152 patients with spinal NTDs. We identified eleven rare and four novel missense mutations in ten CLDN genes. In vivo validation of variant pathogenicity using a chick embryo model system revealed that overexpression of four variants caused a significant increase in NTDs: CLDN3 A128T, CLDN8 P216L, CLDN19 I22T and E209G. Our data implicate rare missense variants in CLDN genes as risk factors for spinal NTDs and identify a new family of proteins involved in the pathogenesis of these malformations.
- 14 July 2020
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 14, 664
Open AccessFunctional Validation of CLDN Variants Identified in a Neural Tube Defect Cohort Demonstrates Their Contribution to Neural Tube Defects
Neural tube defects (NTDs) are severe malformations of the central nervous system that affect 1-2 individuals per 2000 births. Their etiology is complex and involves both genetic and environmental factors. Our recent discovery that simultaneous removal of Cldn3, -4 and -8 from tight junctions results in cranial and spinal NTDs in both chick and mouse embryos suggests that claudins play a conserved role in neural tube closure in vertebrates. To determine if claudins were associated with NTDs in humans, we used a Fluidigm next generation sequencing approach to identify genetic variants in CLDN loci in 152 patients with spinal NTDs. We identified eleven rare and four novel missense mutations in ten CLDN genes. In vivo validation of variant pathogenicity using a chick embryo model system revealed that overexpression of four variants caused a significant increase in NTDs: CLDN3 A128T, CLDN8 P216L, CLDN19 I22T and E209G. Our data implicate rare missense variants in CLDN genes as risk factors for spinal NTDs and identify a new family of proteins involved in the pathogenesis of these malformations.
- Open Access
- 2 October 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (19) , 4889
Temporal Effects of Quercetin on Tight Junction Barrier Properties and Claudin Expression and Localization in MDCK II Cells
Kidney stones affect 10% of the population. Yet, there is relatively little known about how they form or how to prevent and treat them. The claudin family of tight junction proteins has been linked to the formation of kidney stones. The flavonoid quercetin has been shown to prevent kidney stone formation and to modify claudin expression in different models. Here we investigate the effect of quercetin on claudin expression and localization in MDCK II cells, a cation-selective cell line, derived from the proximal tubule. For this study, we focused our analyses on claudin family members that confer different tight junction properties: barrier-sealing (Cldn1, -3, and -7), cation-selective (Cldn2) or anion-selective (Cldn4). Our data revealed that quercetin’s effects on the expression and localization of different claudins over time corresponded with changes in transepithelial resistance, which was measured continuously throughout the treatment. In addition, these effects appear to be independent of PI3K/AKT signaling, one of the pathways that is known to act downstream of quercetin. In conclusion, our data suggest that quercetin’s effects on claudins result in a tighter epithelial barrier, which may reduce the reabsorption of sodium, calcium and water, thereby preventing the formation of a kidney stone.
- 2 October 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (19) , 4889
Open AccessTemporal Effects of Quercetin on Tight Junction Barrier Properties and Claudin Expression and Localization in MDCK II Cells
Kidney stones affect 10% of the population. Yet, there is relatively little known about how they form or how to prevent and treat them. The claudin family of tight junction proteins has been linked to the formation of kidney stones. The flavonoid quercetin has been shown to prevent kidney stone formation and to modify claudin expression in different models. Here we investigate the effect of quercetin on claudin expression and localization in MDCK II cells, a cation-selective cell line, derived from the proximal tubule. For this study, we focused our analyses on claudin family members that confer different tight junction properties: barrier-sealing (Cldn1, -3, and -7), cation-selective (Cldn2) or anion-selective (Cldn4). Our data revealed that quercetin’s effects on the expression and localization of different claudins over time corresponded with changes in transepithelial resistance, which was measured continuously throughout the treatment. In addition, these effects appear to be independent of PI3K/AKT signaling, one of the pathways that is known to act downstream of quercetin. In conclusion, our data suggest that quercetin’s effects on claudins result in a tighter epithelial barrier, which may reduce the reabsorption of sodium, calcium and water, thereby preventing the formation of a kidney stone.